Induction of tumor-specific cytotoxic T lymphocytes from regional lymph node lymphocytes of human breast cancer

Breast Cancer

Volumn 5, Issue 4, 1998, Pages 367-373

  Eifuku, Ryozo ^a   Yoshino, Ichiro ^a   Imahayashi, Satoru ^a   Fujie, Hiroshi ^a   Takenoyama, Mitsuhiro ^a   Yoshimatsu, Takashi ^a   Hanagiri, Takeshi ^a   So, Tomoko ^a   Ichiyoshi, Yuji ^a   Nomoto, Kikuo ^b   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Breast cancer; Cytoxic T lymphocyte; HLA A2

Indexed keywords

EID: 0001381626     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967433     Document Type: Article

References (21)

1. Mukherji B, MacAlister TJ: Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158:240-245, 1983. (Pubitemid 13073525)
2. Knuth A, Danowski B, Oettegen HF, et al: T-cell mediated cytotoxicity against autologous malignant melanoma; Analysis with interleukin 2-mediated T-cell cultures. Proc Natl Acad Sci USA 81:3511-3515, 1984. (Pubitemid 14122704)
3. Herin M, Lemoine C, Weynants P, et al: Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 39:390-396, 1987. (Pubitemid 17038196)
4. Topalian SL, Solomon D, Rosenberg SA: Tumorspecific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142:3714-3725, 1989. (Pubitemid 19137511)
5. Van der Bruggen P, Traversari C, Chomez P, et al: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647, 1991. (Pubitemid 21917508)
6. Travesari C, Van der Bruggen P, Luescer IF, et al: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453-1457, 1992.
7. Peoples GE, Goedegebuure PS, Smith R, et al: Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci USA 92:432-436, 1995.
8. Kawakami Y, Eliyahu S, Delgado CH, et al: Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458-6462, 1994.
9. Whiteford P, Mallon EA, George WD, et al: Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer 62:971-975, 1990.
10. Yoshimoto M, Sakamoto G, Ohashi Y: Time dependency of the influence of prognostic factors on relapse in breast cancer. Cancer 72:2993-3001, 1993. (Pubitemid 23335046)
11. Baxevanis CN, Dedoussis G V Z, Papadopoulos NG, et al: Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 74:1275-1282, 1994. (Pubitemid 24301780)
12. Linehan DC, Goedegebuure PS, Peoples GE, et al: Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer. J Immunol 155:4486-4491, 1995.
13. The Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 12th ed, Kanehara Co, Tokyo, 1996.
14. Yoshino I, Takenoyama M, Fujie H, et al: The induction of cytotoxic T lymphocytes agaisnt HLA-A locus-matched lung adenocarcinoma in patients with non-small cell lung cancer. Jpn J Cancer Res 88:743-749, 1997. (Pubitemid 27404019)
15. Crowley NJ, Slingluff CL, Darrow TL, et al: Generation of human autologous melanoma specific cytotoxic T cell using HLA-A2-matched allogenic melanomas. Cancer Res 50:492-498, 1990. (Pubitemid 20054167)
16. Saito S, Kurisaka M, Mori K, et al: Induction of specific cytotoxic T lymphocytes against autologous brain tumor by cross reactive allo-tumor cell stimulation. Jpn J Cancer Res 88:289-295, 1997. (Pubitemid 27170490)
17. Yang S, Darrow TL, Seigler HF: Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogenic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res 57:1561-1568, 1997. (Pubitemid 27175575)
18. Stevens EJ, Jacknin L, Robbins PF, et al: Generation of tumor-specific CTL melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. J Immunol 154:762-771, 1995.
19. Barnd DL, Lan MS, Metzgar LS, et al: Specific major histocompatibility complex-unrestricted recognition of tumor-associated mucin by human cytotoxic T cells. Proc Natl Acad Sci USA 86:7159-7163, 1988. (Pubitemid 19240884)
20. Jerome KR, Barnd DL, Bendt KM, et al: Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognized an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51:2908-2916, 1991.
21. Akaza T, Imanishi T, Fujiwara K, et al: HLA-A alles and haplotypes of Japanese population. MHC and IRS, Suppl 1:219-226, 1994.